Integrating in vivo and ex vivo approaches for culprit drug identification in cutaneous adverse drug reactions from non-beta lactam antibiotics

Exp Dermatol. 2024 Apr;33(4):e15074. doi: 10.1111/exd.15074.
No abstract available

Keywords: ELISpot; cutaneous adverse reaction; intradermal test; non‐beta lactam antibiotics; oral provocation test.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents* / adverse effects
  • Drug Eruptions / etiology
  • Humans
  • Skin

Substances

  • Anti-Bacterial Agents